Europe Glioblastoma Treatment Drugs Market Size, Share and Growth By Type, By Application and By Country (U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europe) Forecast 2025-2033

Report ID : MS93169
Author : Market Strides
Last Updated : Dec 16, 2024
Pages : 145
Starting From
USD 1850
Buy Now

Table Of Content

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: Europe Glioblastoma Treatment Drugs Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on Europe Glioblastoma Treatment Drugs Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. Europe Glioblastoma Treatment Drugs Market, By Type
    1. Introduction
      1. Market Size and Forecast, By Type
    2. Enzyme Replacement Therapy (ERT
      1. Market Size and Forecast, By Region
  10. Europe Glioblastoma Treatment Drugs Market, By Application
    1. Introduction
      1. Market Size and Forecast, By Application
    2. Life Science Companies
      1. Market Size and Forecast, By Region
    3. Research Institutes
      1. Market Size and Forecast, By Region
    4. Hospital
      1. Market Size and Forecast, By Region
  11. Regional Overview
    1. Introduction
      1. Market Size and Forecast
  12. Competitive Landscape, 2024
    1. Introduction
    2. Europe Glioblastoma Treatment Drugs Market Share Analysis, 2024 (%)
      1. Market Share Analysis, 2024
      2. Competition Ranking, 2024
      3. Key Developments & Growth Strategies
        1. Merger & Acquisition
        2. Product Launch
        3. Expansion
      4. Consolidated SWOT Analysis of Key Players
  13. Company Profile
    1. Takeda
      1. Business Overview
      2. Financial Data
      3. Key Product Categories
      4. Recent Developments
    2. GC Pharma.
    3. JCR Pharmaceuticals Co Ltd.
    4. RegenxBio Inc.
    5. Sangamo Therapeutics
    6. Inc.
    7. ArmaGen Inc.
    8. Inventiva S.A.
    9. Denali Therapeutics Inc.
    10. Bioasis Technologies Inc.
    11. Esteve

	

A PHP Error was encountered

Severity: Warning

Message: Undefined array key "list_tbl_fig"

Filename: reports/toc.php

Line Number: 79

Backtrace:

File: /var/www/html/application/views/frontend/reports/toc.php
Line: 79
Function: _error_handler

File: /var/www/html/application/controllers/Web.php
Line: 215
Function: view

File: /var/www/html/index.php
Line: 316
Function: require_once

Key Topics Covered
  • Market Factors (Including Drivers and Restraint)
  • Market Trends
  • Market Estimates and Forcasts
  • Competitive Analysis
  • Future Market Opportunities
Secured & Verified Premium Quality SSL Certification

Payments Methods